An interventional study of Fructose+maltodextrin placebo and amino-acid + fructose in Metabolic Syndrome, sponsored by University of Lausanne. Completed at 1 site in Switzerland. Open to male participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-05-04.
Sponsored by University of Lausanne · Not applicable, Interventional, and Basic science
10 healthy male volunteers will be studied after
This is a randomized, double blinded study
1,963 studies on the registry are indexed under Metabolic Syndrome; 329 are open to participants now.
This study's enrollment of 9 is below the median of 60 across 1,459 interventional studies indexed under Metabolic Syndrome.
Browse Metabolic Syndrome studies →University of Lausanne is the lead sponsor of 54 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Dietary Supplement: Fructose+maltodextrin placebo
Dietary Supplement: amino-acid + fructose
intrahepatic lipids
Time frame: after 6 days on each controlled diet
13C palmitate synthesis
Time frame: after 6 days on each controlled diet
This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Lausanne